Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Journal of Neurology ; 271 (2023), 1. - S. 141-176. - ISSN 0340-5354. - eISSN 1432-1459

Event: Veröffentlichung

(where): Ulm

(who): Universität Ulm

(when): 2023

Creator: Kümpfel, Tania
Giglhuber, Katrin
Aktas, Orhan
Ayzenberg, Ilya
Bellmann-Strobl, Judith
Häußler, Vivien
Havla, Joachim
Hellwig, Kerstin
Hümmert, Martin W.
Jarius, Sven
Kleiter, Ingo
Klotz, Luisa
Krumbholz, Markus
Paul, Friedemann
Ringelstein, Marius
Ruprecht, Klemens
Senel, Makbule
Stellmann, Jan-Patrick
Bergh, Florian Then
Trebst, Corinna
Tumani, Hayrettin
Warnke, Clemens
Wildemann, Brigitte
Berthele, Achim

DOI: 10.18725/OPARU-54218

URN: urn:nbn:de:bsz:289-oparu-54294-6

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kümpfel, Tania
Giglhuber, Katrin
Aktas, Orhan
Ayzenberg, Ilya
Bellmann-Strobl, Judith
Häußler, Vivien
Havla, Joachim
Hellwig, Kerstin
Hümmert, Martin W.
Jarius, Sven
Kleiter, Ingo
Klotz, Luisa
Krumbholz, Markus
Paul, Friedemann
Ringelstein, Marius
Ruprecht, Klemens
Senel, Makbule
Stellmann, Jan-Patrick
Bergh, Florian Then
Trebst, Corinna
Tumani, Hayrettin
Warnke, Clemens
Wildemann, Brigitte
Berthele, Achim
Universität Ulm

Time of origin

2023

Other Objects (12)

Neuromyelitis optica

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders

The history of neuromyelitis optica

Schwannzell-Remyelinisierung bei Neuromyelitis optica

The history of neuromyelitis optica

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage

Hochschulschrift

Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica

The Gut Microbiome in Neuromyelitis Optica

Neuromyelitis optica

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders

The history of neuromyelitis optica

Schwannzell-Remyelinisierung bei Neuromyelitis optica

The history of neuromyelitis optica

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage

Hochschulschrift

Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica

The Gut Microbiome in Neuromyelitis Optica

Neuromyelitis optica

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders

The history of neuromyelitis optica

Schwannzell-Remyelinisierung bei Neuromyelitis optica

The history of neuromyelitis optica

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage

Hochschulschrift

Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica

The Gut Microbiome in Neuromyelitis Optica

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Neuromyelitis optica

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders

The history of neuromyelitis optica

Schwannzell-Remyelinisierung bei Neuromyelitis optica

The history of neuromyelitis optica

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage

Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica

The Gut Microbiome in Neuromyelitis Optica

Neuromyelitis optica

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders

The history of neuromyelitis optica

Schwannzell-Remyelinisierung bei Neuromyelitis optica

The history of neuromyelitis optica

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage

Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica

The Gut Microbiome in Neuromyelitis Optica

Neuromyelitis optica

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders

The history of neuromyelitis optica

Schwannzell-Remyelinisierung bei Neuromyelitis optica

The history of neuromyelitis optica

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage

Ergebnisse der Cortisonbehandlung bei Neuromyelitis optica

The Gut Microbiome in Neuromyelitis Optica

Related objects

Reset password